What are 3 drugs produced by Bristol Myers Squibb?
What are 3 drugs produced by Bristol Myers Squibb?
Our Medicines
- ABECMA® (idecabtagene vicleucel)
- ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)
- AZACTAM® (aztreonam for injection, USP)
- BREYANZI® (lisocabtagene maraleucel)
- BARACLUDE® (entecavir)
- DROXIA® (hydroxyurea)
- ELIQUIS® (apixaban)
- EMPLICITI® (elotuzumab)
How many products does Bristol Myers Squibb have?
Drugs Associated with Bristol-Myers Squibb Company Bristol-Myers Squibb Company manufactures, markets and/or distributes more than 36 drugs in the United States.
What is unique about Bristol Myers Squibb?
Bristol Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm.
What type of business is Bristol Myers Squibb?
biopharmaceutical company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
Where is Bristol Myers Squibb headquartered?
New York, NY
Bristol Myers Squibb/Headquarters
What are Bristol Myers Squibb values?
The health, safety, professional development, work-life balance and equitable, respectful treatment of our employees are among our highest priorities. We commit to ensuring our colleagues have opportunities for development and advancement.
Is Bristol Myers Squibb a good company?
BMS is a very well renowned and successful pharmaceutical company, with many resources for training new hires as well as providing info to full-time employees. Compensation tends to be very fair, and the working conditions are very manageable.
Which company owns eliquis?
Pfizer
BMS and Pfizer co-developed Eliquis and share profits and losses on a 40/60 basis, respectively. The U.S. Food and Drug Administration approved the first generics for Eliquis in December 2019. Eliquis (apixaban) is an oral Factor Xa inhibitor.
